The present invention is directed to a composition comprising rapeseed protein, a hydrocolloid, and a vegetable oil, and to the use of such composition in food products such as a beverage.
A23L 25/00 - Food consisting mainly of nutmeat or seedsPreparation or treatment thereof
A23L 29/262 - CelluloseDerivatives thereof, e.g. ethers
A23L 29/269 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
2.
A METHOD FOR PROVIDING AN AMORPHOUS HMO PRODUCT BY DRYING
A method for providing a solid amorphous HMO product, said method including drying an aqueous composition of said HMO. Solid amorphous HMO product is obtained via said method, as well as solid amorphous HMO product per se.
The present invention relates to a yeast extract comprising free glutamate in an amount of at least 7 wt. % on salt free dry matter and comprising an amount of 5′-ribonucleotides of at least 10 wt. % on salt free dry matter.
The present invention relates to cosmetic composition comprising UV-filter(s), an ester of a fatty acid and dextrin and a mixture of branched and linear saturated C15-C19, wherein said mixture comprised primarily branched saturated C15-C19 and a specific cellulose derivative. This cosmetic composition shows a significantly increased water resistance.
The present invention relates to methods of reducing material transfer of cosmetic compositions which include at least one liquid dispersion of an acrylic polymer by incorporating into the cosmetic compositions an amount of a hyperbranched copolymer sufficient to reduce material transfer of the cosmetic composition, wherein the hyperbranched copolymer is a copolymerization reaction product of the monomers dodecenyl succinic acid anhydride, diisopropanol amine and bis-dimethylaminopropyl amine having quaternary terminal groups and at least one liquid dispersion of an acrylic polymer which is a homopolymer or a copolymer of the monomers selected from the group consisting of (meth)acrylic acid, (meth)acrylic esters, (meth)acrylamide and amides of (meth)acrylic acid.
A61K 8/81 - Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
The present disclosure relates generally to the production of glycosylated compounds. Provided is a recombinant cell and a method for enzymatically modifying a glycosyl acceptor. The method comprises contacting a recombinant cell producing sucrose with a glycosyl acceptor and 5 at least one enzyme capable of catalyzing the transfer of a glycosyl group from sucrose to the glycosyl acceptor; thereby producing a modified glycosyl acceptor. Also provided is a composition obtainable by a method of the disclosure, and the use thereof.
C12P 19/56 - Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin
C12P 19/18 - Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
The present disclosure relates to methods of feeding animals by providing feed additives that modulate the gut microbiome to improve the health, nutrition, and growth performance. The present disclosure further relates to methods of modulating metabolites present in the gastrointestinal tract of an animal. Such modulation includes, for example, modulating the level said metabolites.
A23K 50/10 - Feeding-stuffs specially adapted for particular animals for ruminants
A23K 50/30 - Feeding-stuffs specially adapted for particular animals for swine
A23K 50/75 - Feeding-stuffs specially adapted for particular animals for birds for poultry
A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates
A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
8.
CELLS AND METHODS FOR THE PRODUCTION OF GLYCOSYLATED COMPOUNDS
The present disclosure relates generally to the production of glycosylated compounds. Provided is a recombinant cell and a method for enzymatically modifying a glycosyl acceptor. The method comprises contacting a glycosyl donor and a glycosyl acceptor with a recombinant cell comprising a heterologous enzyme capable of catalyzing the transfer of a glycosyl group from the glycosyl donor to the glycosyl acceptor; thereby producing a modified glycosyl acceptor. Also provided is a composition obtainable by a method of the disclosure, and the use thereof.
45 - Legal and security services; personal services for individuals.
42 - Scientific, technological and industrial services, research and design
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Business assistance and administrative services in the pharmaceutical field; supply chain management services in relation to the pharmaceutical field; retail and wholesale of ingredients for pharmaceuticals Legal services and advice in relation to compliance regulations in the pharmaceutical field; consultation in relation to compliance in the pharmaceutical field; regulatory compliance consulting and auditing services for the pharmaceutical industry; reviewing standards and practices to assure compliance with local laws and regulation in relation to the pharmaceutical field Consultancy relating to pharmaceutical research and development Pharmaceutical consultation
The present invention relates sunscreen compositions comprising ethylhexyl triazone and 2-ethylhexyl 2-hydroxycyclohexanecarboxylate as well as to the use of 2-ethylhexyl 2-hydroxycyclohexanecarboxylate as effective solubiliser for ethylhexyl triazone.
The present invention relates sunscreen compositions comprising 2-ethylhexyl 2-hydroxycyclohexanecarboxylate, bis-ethylhexyloxyphenol methoxyphenyl triazine and at least one UV-filter selected from butyl methoxy dibenzoyl methane, diethylamino hydroxybenzoyl hexyl benzoate and ethylhexyl triazone as well as to the use of butyl methoxy dibenzoyl methane, diethylamino hydroxybenzoyl hexyl benzoate and/ or ethylhexyl triazone to increase the solubility of bis-ethylhexyloxyphenol methoxyphenyl triazine in 2-ethylhexyl 2-hydroxycyclohexanecarboxylate.
The present invention relates to synthesis of carboxy group terminated di-unsaturated ketones having C=C double bonds at the α,β and γ,δ position or at the β,γ and γ,δ position relative to the carbonyl carbon atom. These ketones can be obtained easily and in few steps from respective alkynols having a terminal carboxyl group. These ketones are important key building block for the synthesis of derivatives of isoprenoids, especially of vitamin E.
C07C 51/36 - Preparation of carboxylic acids or their salts, halides, or anhydrides by reactions not involving formation of carboxyl groups by hydrogenation of carbon-to-carbon unsaturated bonds
C07C 51/373 - Preparation of carboxylic acids or their salts, halides, or anhydrides by reactions not involving formation of carboxyl groups by introduction of functional groups containing oxygen only in doubly bound form
C07D 311/72 - 3, 4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
The present invention relates to an aquaculture feed composition for carnivorous fish with an improved sustainability profile where Forage Fish Dependency Ratio (FFDR) is reduced by use of a single cell protein (SCP) as a partially or complete replacement of fish-meal, optionally used in combination with a non-marine or vegetable oil and to the use of a Single Cell Protein (SCP) composition in an aquaculture feed composition for carnivorous fish for partially or completely replacing the fishmeal component.
The present invention relates to the field of reduction of methane emission in ruminants. Particularly, it relates to the administration of Iodoform in an amount of at least 0.5 g Iodoform/ animal/ day to a ruminant for reducing the production of methane emanating from the digestive activities of said ruminant.
The present invention relates to the field of reduction of methane emission in ruminants. Particularly, it relates to the administration of Linolic acid in an amount of at least 0.5 g Linolic acid/ animal/ day to a ruminant for reducing the production of methane emanating from the digestive activities of said ruminant.
The present invention relates to the field of reduction of methane emission in ruminants. Particularly, it relates to the administration of 3-iodopropionic acid in an amount of at least 0.5 g 3-iodopropionic acid/ animal/ day to a ruminant for reducing the production of methane emanating from the digestive activities of said ruminant.
The present invention relates to the field of reduction of methane emission in ruminants. Particularly, it relates to the administration of Anacardic acid in an amount of at least 0.5 g Anacardic acid/ animal/ day to a ruminant for reducing the production of methane emanating from the digestive activities of said ruminant.
The present invention relates to the field of reduction of methane emission in ruminants. Particularly, it relates to the administration of Metronidazol in an amount of at least 0.5 g Metronidazol/ animal/ day to a ruminant for reducing the production of methane emanating from the digestive activities of said ruminant.
The present invention relates to the field of reduction of methane emission in ruminants. Particularly, it relates to the administration of Diiodomethane in an amount of at least 0.5 g Diiodomethane/ animal/ day to a ruminant for reducing the production of methane emanating from the digestive activities of said ruminant.
The present invention relates to synthesis of specific allylic alcohols having terminal carboxyl groups based on steps of ethynylation and hydrogenation in the presence of a Lindlar catalyst. These allylic alcohols are particularly useful to offer pathways to syntheses of isophytol or tocopherols having a terminal carboxyl group by a very small number of reactions steps.
C07C 51/36 - Preparation of carboxylic acids or their salts, halides, or anhydrides by reactions not involving formation of carboxyl groups by hydrogenation of carbon-to-carbon unsaturated bonds
C07C 51/367 - Preparation of carboxylic acids or their salts, halides, or anhydrides by reactions not involving formation of carboxyl groups by introduction of functional groups containing oxygen only in singly bound form
C07C 51/373 - Preparation of carboxylic acids or their salts, halides, or anhydrides by reactions not involving formation of carboxyl groups by introduction of functional groups containing oxygen only in doubly bound form
C07C 57/00 - Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
The present invention relates to the field of reduction of methane emission in ruminants. Particularly, it relates to the administration of a combination of 3-nitrooxypropanol and/or derivatives thereof and Linolic acid to a ruminant for reducing the production of methane emanating from the digestive activities of said ruminant.
The present invention relates to the field of reduction of methane emission in ruminants. Particularly, it relates to the administration of a combination of 3-nitrooxypropanol and/or derivatives thereof and Metronidazol to a ruminant for reducing the production of methane emanating from the digestive activities of said ruminant.
The present invention relates to the field of reduction of methane emission in ruminants. Particularly, it relates to the administration of Urea hydrogen peroxide in an amount of at least 0.5 g Urea hydrogen peroxide/ animal/ day to a ruminant for reducing the production of methane emanating from the digestive activities of said ruminant.
The present invention relates to the field of reduction of methane emission in ruminants. Particularly, it relates to the administration of 2-iodoethanol in an amount of at least 0.5 g 2-iodoethanol/ animal/ day to a ruminant for reducing the production of methane emanating from the digestive activities of said ruminant.
The invention concerns a polymer composition for making a bone anchoring part of an orthopedic implant for use in repair of damaged cartilage tissue, comprising a biostable thermoplastic polyurethane and 15-70 mass % of micron-sized inorganic particles comprising a biocompatible transition metal compound. It was found that the relatively rigid TPU composition comprising said inorganic particles allows making an anchoring part that can be inserted or press-fitted into a pre-drilled bone hole to form a firm and durable connection to bone tissue, and which may be visualized with for example X-ray or MRI methods. The polymer composition shows favorable properties and enables freedom in designing and making the implant with common techniques like injection molding. In other aspects, the invention relates to methods of making said polymer composition, and to using the polymer composition in making an orthopedic implant comprising a bone anchoring part, like in forming the implant with a multi-component injection molding process comprising a step of molding the bone anchoring part from the polymer composition.
The present invention relates to a novel use of proline containing dipeptides for evening out as well as brightening the skin tone. These proline containing dipeptides are furthermore particular suitable for improving the skin tone of the cheek under the eyes, on the cheek and the jawline.
The present disclosure relates to methods of feeding animals by providing feed additives that modulate the gut microbiome to improve the health, nutrition, and growth performance. The present disclosure further relates to methods of modulating metabolites present in the gastrointestinal tract of an animal. Such modulation includes, for example, modulating the level said metabolites.
A23K 50/10 - Feeding-stuffs specially adapted for particular animals for ruminants
A23K 50/30 - Feeding-stuffs specially adapted for particular animals for swine
A23K 50/75 - Feeding-stuffs specially adapted for particular animals for birds for poultry
A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates
A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
28.
METHODS OF MODULATING GASTROINTESTINAL METABOLITES
The present disclosure relates to methods of feeding animals by providing feed additives that modulate the gut microbiome to improve the health, nutrition, and growth performance. The present disclosure further relates to methods of modulating metabolites present in the gastrointestinal tract of an animal. Such modulation includes, for example, modulating the level said metabolites.
A23K 50/10 - Feeding-stuffs specially adapted for particular animals for ruminants
A23K 50/30 - Feeding-stuffs specially adapted for particular animals for swine
A23K 50/75 - Feeding-stuffs specially adapted for particular animals for birds for poultry
A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates
A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
29.
METHODS OF MODULATING GASTROINTESTINAL METABOLITES
The present disclosure relates to methods of feeding animals by providing feed additives that modulate the gut microbiome to improve the health, nutrition, and growth performance. The present disclosure further relates to methods of modulating metabolites present in the gastrointestinal tract of an animal. Such modulation includes, for example, modulating the level said metabolites.
A23K 50/10 - Feeding-stuffs specially adapted for particular animals for ruminants
A23K 50/30 - Feeding-stuffs specially adapted for particular animals for swine
A23K 50/75 - Feeding-stuffs specially adapted for particular animals for birds for poultry
A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates
A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
01 - Chemical and biological materials for industrial, scientific and agricultural use
05 - Pharmaceutical, veterinary and sanitary products
31 - Agricultural products; live animals
Goods & Services
Mixtures of chemicals and microorganisms for increasing the
nutritional value of animal fodder other than for veterinary
use; biological preparations for use in the manufacture of
feed and feed additives; protein for use in the manufacture
of foodstuffs; proteins for the food industry; proteins for
use in animal feed and feed supplement manufacturing
processes; proteins for use in the manufacture of beverages;
protein for food for human consumption; proteins for use in
the manufacture of food products. Foods and foodstuffs intended for medical or veterinary use;
food supplements for humans and animals; dietary supplements
for humans and animals; protein supplements for humans and
animals; food for babies; veterinary preparations; feed
additives for animals; dietetic beverages adapted for
medical purposes; dietary supplement drinks. Foodstuffs for animals; additives to fodder; formula animal
feed not for medical purposes; animal fattening
preparations; animal beverages; pet beverages.
31.
METHODS OF MODULATING GASTROINTESTINAL METABOLITES
The present disclosure relates to methods of feeding animals by providing feed additives that modulate the gut microbiome to improve the health, nutrition, and growth performance. The present disclosure further relates to methods of modulating metabolites present in the gastrointestinal tract of an animal. Such modulation includes, for example, modulating the level said metabolites.
A23K 50/10 - Feeding-stuffs specially adapted for particular animals for ruminants
A23K 50/30 - Feeding-stuffs specially adapted for particular animals for swine
A23K 50/75 - Feeding-stuffs specially adapted for particular animals for birds for poultry
A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates
A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
32.
SUCROSE ISOMERASES AS FOOD AND NUTRITIONAL SUPPLEMENTS
Sucrose isomerase is used as a nutritional supplement, or can be mixed in with a powderous food/beverage formulation. When an animal, including a human, consumes sucrose, the sucrose isomerase will act on the sucrose present in the food, and will convert the sucrose to other sugars. This results in lowering of the glycemic index of the food without changing the formulation of the food.
The present invention relates to a process of oxidation of 2,3,6-trimethyl phenol by oxygen or an oxygen-containing gas in the presence of in the presence of a copper (II) halide as catalyst and of water and a specific diol comprising at least on tertiary hydroxyl group as reaction medium.
C07C 46/08 - Preparation of quinones by oxidation giving rise to quinoid structures of at least one hydroxy group on a six-membered aromatic ring with molecular oxygen
C07C 50/02 - Quinones with monocyclic quinoid structure
The present invention relates to a new formulation comprising a mixture of lutein and zeaxanthin in a specific ratio, polysorbate and water. The formulation can be used in a variety of products (such food, feed, dietary supplements, pharmaceuticals, or other products).
A23L 5/44 - Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives using carotenoids or xanthophylls
A23L 29/10 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing emulsifiers
35.
DEGRADABLE PARTICLES COMPRISING HIGH LEVELS OF RAPAMYCIN
Disclosed are drug delivery devices, coatings, and microparticles that achieve sufficiently small particle sizes with high loading of Rapamycin. In an embodiment, a balloon comprises a coating on its exterior surface, the coating comprising microparticles having a Dv90 particle size of from 1 to 11 μm, as measured with static laser scattering, the microparticles comprising from 35 to 50 wt % of rapamycin, based on the total weight of the microparticles, and a random copolymer according to Formula (I).
03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
Goods & Services
Cosmetics and cosmetic preparations, also for make-up,
beauty, eye care, scalp care, foot care, lip care, hair
care, face care, body care, skin care and hand care;
cosmetics, make-up, eye care products, hair care products,
scalp care products, foot care products, lip care products,
face care products, body care products, skin care products
and hand care products for the prevention of sunburn;
sun-tan and sun-screening preparations; sun care
preparations; compounds for skin care after exposure to the
sun's rays; preparations and substances for the
conditioning, cleaning, care, treatment and beautification
and appearance of the eye, skin, body, face, scalp, hair,
foot, lips and hand (non-medicated).
The present invention relates to the use of neutral core human milk oligosaccharides such as in particular lacto-N-(neo)tetraoses as anti-ageing active ingredient as well as the use thereof in topical anti-ageing compositions.
The present invention relates to a new formulation, which comprises a high amount of retinol, which has a defined mixture of cis and trans isomers, in a specific solvent and in the presence of mixed tocopherol.
The present invention relates to the use of selected UV filters selected from the group consisting of octocrylene, ethylhexyl salicylate and butyl methoxydibenzoylmethane to reduce the abundance of C. acnes strains in a skin microbiome after UV radiation. Said use is suitable to prevent and or treat the progression of acne, in particular the progression of acne exacerbated by sunscreen application.
The present invention relates to a method for modulating the level of one or more secondary metabolite(s), and a use for modulating the level of one or more secondary metabolite(s) in the gastrointestinal tract of an animal.
Polyesteramide (PEA) copolymers are disclosed, having structures that include repeating units that contain various monomer residues characterized herein and present in the repeating units at defined ranges of molar equivalents. These copolymers can possess a number of important advantages for providing longer performing glucose sensors and/or for simplifying their design. For example, in vivo modeling has confirmed that these polymers exhibit both decreased collagen deposition and increased neovascularization (angiogenesis). Additional testing has demonstrated favorable oxygen and glucose transport capabilities, as well as other relevant properties.
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61B 5/1486 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
The present invention relates to the use of certain 4-amidino benzylamines as ingredient to increase skin firmness and elasticity by increasing type I collagen expression in the skin.
The present invention relates to cosmetic skin care compositions which comprise a hyperbranched copolymer of the monomers dodecenyl succinic acid anhydride, diisopropanol amine and bis-dimentheylaminopropyl amine having quaternary terminal groups and at least one non-ionic emulsifier being an ether or an ester of (poly)ethylene glycol.
The present invention relates to an animal feed comprising up to 20% (w/w) yeast single cell protein product, wherein the yeast single cell protein product comprises Saccharomycesales yeast cells, as well as to the use of said animal feed for feeding an animal and/or for increasing body weight of an animal.
The present invention relates to a process for the production of an intermediate, which is useful in organic synthesis, especially in the production of astaxanthin.
C07C 403/08 - Derivatives of cyclohexane or of a cyclohexene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by hydroxy groups
C07C 403/24 - Derivatives of cyclohexane or of a cyclohexene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by six-membered non-aromatic rings, e.g. beta-carotene
A polypeptide, wherein the polypeptide has an amino acid sequence which, when aligned with the amino acid sequence set out in SEQ ID NO: 1, comprises at least a substitution of the amino acid residues corresponding to the amino acids in positions 50, 51, 126, 135 and 221, wherein said positions are defined with reference to SEQ ID NO: 1.
The present invention relates to a combination of a human milk oligosaccharides (HMOs) and inanimate cell of a microorganism, compositions comprising the combination and the use of the combination or the compositions to promote lactate and or GABA production in the gut of a mammal.
The present invention relates to a combination of a human milk oligosaccharides (HMOs) and inanimate cell of a microorganism, compositions comprising the combination and the use of the combination or the compositions to promote GABA production in the gut of a mammal.
The present invention relates to a new formulation, which comprises a high amount of retinol, which has a defined mixture of cis and trans isomers, in a specific solvent and in the presence of mixed tocopherol.
The present disclosure describes nutritional oils and methods of producing nutritional oils including a LC-PUFA and having a MOSH content of less than or equal to 7 ppm.
The present invention is related to fermentative production of hydroxylated derivatives of vitamin D3 in an oleaginous host cell, particularly a host selected from Yarrowia lipolytica.
A polypeptide comprising: a) a chymosin activity with a C/P ratio of clotting activity (C) to proteolytic activity (P) equal to or higher than the C/P ratio of a polypeptide having an amino acid sequence of SEQ ID NO: 2; and b) an alpha-S1-I casein fragment formation activity equal to or higher than the alpha-S1- I casein fragment formation activity of a polypeptide having an amino acid sequence of SEQ ID NO: 2; and/or c) a clotting time at pH 6.1 of equal to or less than the clotting time of a polypeptide having an amino acid sequence of SEQ ID NO: 2.
The present invention relates to the field of reduction of methane emission in ruminants. Particularly, it relates to the administration of at least one strain of the bacterial genus Acetobacter or the archaeal genus Methanobrevibacter and propanediol mononitrate to a ruminant for reducing the production of methane emanating from the digestive activities of said ruminant.
The invention relates to a dry extrusion process for preparing a texturized vegetable protein, to a composition comprising rapeseed protein, a legume-derived protein, and a plant-based fiber, to the use of said composition in the preparation of a meat alternative and to meat alternatives.
The present disclosure relates to the production of sialylated Human Milk Oligosaccharides (HMOs), in particular to the biosynthetic production of 3′-sialyllactose (3′SL), and to genetically engineered cells and methods suitable for said production.
C07K 14/24 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
C12P 19/04 - Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
C12P 19/18 - Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
57.
USE OF A METHANE INHIBITOR IN COMBINATION WITH A PROBIOTIC STRAIN TO REDUCE METHANE EMISSIONS FROM RUMINANTS
The present invention relates to the field of reduction of methane emission in ruminants. Particularly, it relates to the administration of at least one probiotic strain and propanediol mononitrate to a ruminant for reducing the production of methane emanating from the digestive activities of said ruminant.
Rosa RoxbunghiiRosa Roxbunghii and a method of preparation thereof. The freeze-dried powder of the present invention surprisingly provides light-color, uniform and stable cake appearance in penicillin vial and efficiently prevents degradation of vitamin C comprised in the powder.
The present invention relates to the use of a mixture of a) 2'-fucosyllactose (2'-FL) or 3'-sialyllactose (3'-SL); and b) a compound selected from the group consisting of group consisting of 3-[(2-ethylhexyl)oxy]-1,2-propanediol (=ethylhexylglycerin), propane-1,2-diol, propane-1,3-diol, glyceryl caprylate, pentane-1,2-diol, heptane-1,2-diol and hydroxyacetophenone for reducing the growth of microbes.
A61Q 17/00 - Barrier preparationsPreparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
The present invention relates to a meat analogue product comprising a texturized vegetable protein, a binder, a flavor and 0.5 to 10% (w/w) of a yeast single cell protein product, wherein the yeast single cell protein product comprises Saccharomycetales yeast cells or parts thereof.
The present invention relates to a new formulation, which comprises a high amount of retinol, which has a defined mixture of cis and trans isomers, in a specific solvent and in the presence of mixed tocopherol.
A61K 47/14 - Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
A61K 47/22 - Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
A61K 47/24 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
The present invention relates to cosmetic compositions comprising a combination of lacto-N-tetraose (LNT) or lacto-N-neotetraose (LNnT); and hydroxyacetophenone. Said cosmetic compositions, respectively said combinations show a significant antimicrobial effect on microbes.
A61Q 17/00 - Barrier preparationsPreparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
63.
COSMETIC COMPOSITION COMPRISING LACTO-N-TETRAOSE OR LACTO-N-NEOTETRAOSE AND A DIOL OR TRIOL OR ITS ETHER OR ESTER
The present invention relates to cosmetic compositions comprising a combination of lacto-N-tetraose (LNT) or lacto-N-neotetraose (LNnT); and an aliphatic diol or aliphatic triol or an ether or an ester thereof. These cosmetic compositions, respectively said combinations, show a significant antimicrobial effect on microbes.
A61Q 17/00 - Barrier preparationsPreparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
The invention relates to a method for recovery and purification of human milk oligosaccharides (HMOs) from a fermentation broth, comprising the steps of separating the fermentation broth to form a separated HMO-containing stream and a biomass waste stream, purifying the separated HMO-containing stream, concentrating the purified HMO-containing stream, and drying the purified HMO-containing stream to obtain solidified HMO. Moreover, the invention also concerns a human milk oligosaccharide obtained by the inventive method, as well as its use in food, feed, and medical application.
The present disclosure provides a method for increasing production of a polyunsaturated fatty acid, especially eicosapentaenoic acid (EPA), in a microorganism, comprising adjusting the macro-and/or micronutrients during fermentation. The invention includes any culture, biomass, and oil produced by the method.
The present disclosure relates to the production of complex fucosylated Human Milk Oligosaccharides (HMOs) and in particular to the production of the complex fucosylated HMO LNFP-VI or LNFP-V, with five or more monosaccharide units, where said production leads to a product which is essentially free of LNFP-III and LNDFH-III, or LNFP-II and LNADH-II, respectively using alpha-1,3-fucosyltransferases from Bacteroidales bacterium. The present disclosure also relates to genetically engineered cells and alpha-1,3-fucosyltransferases suitable for use in said production, as well as to methods for producing said fucosylated HMOs.
C12P 19/18 - Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
01 - Chemical and biological materials for industrial, scientific and agricultural use
Goods & Services
Hydrocolloids, gelling agents, thickening agents,
stabilizers, emulsifiers, binding agents, gums, modified
starches, pectins and fibers for use in the manufacture of
food and beverage products, pharmaceuticals, personal care
products and cosmetics.
01 - Chemical and biological materials for industrial, scientific and agricultural use
Goods & Services
Additives for food and beverages, namely DHA algae oil
(docosahexaenoic acid) extracted from algae strains;
cultures and fermented preparations of microorganisms for
industrial use for the production of food, beverages, namely
DHA algae oil (docosahexaenoic acid) extracted from algae
strains; chemical and biochemical preparations relating to
microbiologically produced products for industrial use for
the production of food, beverages, namely DHA algae oil
(docosahexaenoic acid) extracted from algae strains;
additives for food manufacturing, namely DHA algae oil
(docosahexaenoic acid) extracted from algae strains; fatty
acids for food manufacturing, namely DHA algae oil
(docosahexaenoic acid) extracted from algae strains; plant
extracts, other than essential oils, for the food industry,
namely DHA algae oil (docosahexaenoic acid) extracted from
algae strains.
Methods for sustainably producing a pet food product and the pet food products thereby produced include formulating a pet food product by replacing all or part of fish oil in a pet food product composition with a single microbial source of eicosapentaenoic acid (“EPA”) and docosahexaenoic acid (“DHA”). In a preferred embodiment, the microbial source comprising DHA and EPA derives from a microorganism/microbe of the genus Schizochytrium or Thraustochytrium.
The disclosed inventions pertain to solid extrudates for pharmaceutical use. The solid extrudates comprise at least one cannabinoid isolate and may be produced by hot melt extrusion. In an embodiment, a solid extrudate comprises 20-40 wt% of a cannabinoid isolate, 20-40 wt% of a hydroxypropyl methylcellulose, 5-15 wt% of a monounsaturated fatty acid, and 10-30 wt% of a surfactant.
In an embodiment, a polyurethane comprises the residues of i. an aliphatic diisocyanate, ii. an aliphatic diol comprising a poly(ethylene oxide) moiety, iii. an aliphatic diol comprising a polycarbonate moiety, and iv. a chain extender, wherein the polyurethane has a melting temperature of 140° C. or less and has a weight average molecular weight of from 100,000 to 500,000 g/mol. In an embodiment, the polyurethane is substantially devoid of catalyst. In an embodiment, the polyurethane is formed by reactive extrusion. In an embodiment, a medical device comprises the polyurethane and a bioactive agent. The medical devices, methods, and polyurethanes may exhibit benefits in end-product biostability, drug release profile, health and safety, and processing speed or reproducibility.
A61L 31/06 - Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
A61L 29/06 - Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
C08G 18/12 - Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step using two or more compounds having active hydrogen in the first polymerisation step
The present invention discloses a LC-PUFA biomass composition which has reduced self-heating propensity and thus requires a lessened packing requirement for shipment. The invention also discloses methods for making such biomass composition.
C12N 1/00 - Microorganisms, e.g. protozoaCompositions thereofProcesses of propagating, maintaining or preserving microorganisms or compositions thereofProcesses of preparing or isolating a composition containing a microorganismCulture media therefor
C12N 1/12 - Unicellular algaeCulture media therefor
The present invention relates to relates to the field of food. Disclosed is a method for preparing soy or almond protein comprising coffee or tea, comprising adding soy or almond protein to coffee or tea and wherein said soy or almond protein is a protein arginine deiminase (PAD) or proline-specific endoprotease (PSP) treated soy or almond protein.
A23C 11/10 - Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
The present invention relates to a process for reducing an amount of phospholipids in an oil composition using an enzyme having phospholipase A2 activity.
The present invention is related to a novel process on biological production of lipophilic substances in an oleaginous host cell, particularly Yarrowia lipolytica, comprising modification in the N-glycosylation pathway, leading to higher yield and product purity with further facilitating the overall production process.
C12P 23/00 - Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
The present invention relates to a method for modifying a trichothecene, a mutant variant of a polypeptide, an additive, methods for manufacturing, a use of the polypeptide, a polynucleotide, a recombinant host cell, and a polypeptide for use in treatment, amelioration and/or prophylaxis of symptoms caused by mycotoxicosis.
01 - Chemical and biological materials for industrial, scientific and agricultural use
03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
Goods & Services
Chemical and biochemical products and preparations for use in the manufacture of cosmetics, eye care products, hair care products, scalp care products, skin care products, body care products, make-up products, lip care products and sun care products; synthetic agents and biotech agents for use in the manufacture of cosmetics, eye care products, hair care products, scalp care products, skin care products, body care products, make-up products, lip care products and sun care products. Cosmetics and cosmetic preparations, also for make-up, beauty, eye care, scalp care, foot care, lip care, hair care, face care, body care, skin care and hand care; Cosmetics, make-up, eye care products, hair care products, scalp care products, foot care products, lip care products, face care products, body care products, skin care products and hand care products for the prevention of sunburn; Sun-tan and sun-screening preparations; sun care preparations.
01 - Chemical and biological materials for industrial, scientific and agricultural use
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Probiotic preparations for use in the dietary supplement
industry; prebiotic preparations for use in the dietary
supplement industry; postbiotic preparations for use in the
dietary supplement industry; probiotics for use in the
manufacture of nutraceuticals; prebiotics for use in the
manufacture of nutraceuticals; postbiotics for use in the
manufacture of nutraceuticals; probiotic and prebiotic
bacteria for the food industry; probiotic or prebiotic
bacterial formulations (other than for medical use);
cultures of microorganisms other than for medical or
veterinary use; bacteria, molecules and microorganisms for
addition to dietary supplements and food products. Dietary supplements; probiotic preparations for medical
purposes; prebiotic supplements; probiotic supplements;
postbiotic supplements; microbiome preparations for dietary
purposes.
79.
MICROBIAL STRAIN EXPRESSING AN INVERTASE/SUCROSE HYDROLASE
The present disclosure relates to a genetically modified cell capable of utilizing sucrose as energy and carbon source following the expression of a single heterologous enzyme, which upon expression is translocated from the cytosol and which is capable of hydrolysing non-phosphorylated sucrose into fructose and glucose.
The present disclosure relates to a genetically modified cell capable of utilizing sucrose as energy and carbon source following the expression of a single heterologous enzyme, which upon expression is translocated from the cytosol and which is capable of hydrolysing non-phosphorylated sucrose into fructose and glucose.
The identification of efficient enzymes capable of hydrolysing sucrose in its non-modified form, and which on its own enable the cell to utilize sucrose as a, or as the main and/or sole, carbon and/or energy source, i.e., without the need for multi-gene sucrose utilizing systems comprising several other heterologous polypeptides, such as other enzymes and/or transporters, is highly advantageous, since it allows for cost-effective use of sucrose in large scale production processes.
PROCESS FOR PRODUCING A FERMENTED MILK PRODUCT WITH AID OF STRAINS OF STREPTOCOCCUS THERMOPHILUS HAVING NO OR LIMITED SALT-ACCOMPANIED NISIN-DEACTIVATING ACTIVITY
The present invention relates to a new process for producing a fermented milk product, preferably cheese. In addition, the present invention relates to a new bacterial culture, starter culture and kit of parts for use in such a process.
The present invention relates to a composition for aquatic animals comprising as active ingredient 25-hydroxyvitamin D, preferably 25-hydroxy vitamin D3 (25-OH D3). The present invention further relates to the use of 25-hydroxyvitamin D, preferably 25-hydroxyvitamin D3 (25-OH D3), as feed additive for aquatic animals including fish and shrimp. More particular, this invention relates to the use of 25-hydroxyvitamin D, preferably 25-hydroxyvitamin D3 (25-OH D3), for improving feed utilization and growth and performance parameters of the animals, such as the feed conversion ratio (FOR). Immunity, protein efficiency ratio (PER), specific growth rate (SGR), final body weight, feed efficiency (FE), nutrient utilization, body protein content, and/or carcass yield and/or for increasing levels of Vitamin D, preferably Vitamin D3, in the blood of aquatic animals.
A23K 40/25 - Shaping or working-up of animal feeding-stuffs by extrusion
A23K 40/30 - Shaping or working-up of animal feeding-stuffs by encapsulatingShaping or working-up of animal feeding-stuffs by coating
A23K 50/80 - Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
The present invention relates to a method of reducing methane emissions in ruminants, said method encompassing treating pre-/young ruminants with 3-nitrooxypropanol.
The present invention relates to improved carrier systems for 3-nitrooxypropanol and derivatives thereof as well as to the production of such formulations.
A23K 10/30 - Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hayAnimal feeding-stuffs from material of fungal origin, e.g. mushrooms
The invention relates to non-liposomal lipid matrix-based particles of nutrients, particularly of water-soluble vitamins, showing a continuous release of the nutrient throughout the small intestine, and a method of manufacturing it. The non-liposomal lipid matrix-based particles of nutrients are intended for use in food, agricultural, personal care, cosmetic, manufacturing, or pharmaceutical applications, and particularly in supplementation applications.
A61K 31/375 - Ascorbic acid, i.e. vitamin CSalts thereof
A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
A61K 47/24 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
85.
USE OF WHEY AND PROPANEDIOL MONONITRATE TO REDUCE METHANE EMISSION OF RUMINANTS
The present invention relates to the field of reduction of methane emission in ruminants. Particularly, it relates to the administration of whey and propanediol mononitrate to a ruminant for reducing the production of methane emanating from the digestive activities of said ruminant.
01 - Chemical and biological materials for industrial, scientific and agricultural use
03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
42 - Scientific, technological and industrial services, research and design
Goods & Services
chemical and biochemical preparations for use in skin care products, moisturizers, skin care products for the prevention of sunburn, sun creams, sun-tan products and sun-screen products for the absorption of ultraviolet. skin care products for the prevention of sunburn; sun-tan and sun-screening preparations; sun creams; cosmetics and skin care products; preparations and substances for the conditioning, care and appearance of the skin, body and face; moisturizers. advisory services relating to environmental pollution; advisory services relating to environmental protection; advisory services relating to the environmental safety of sun-tan and sun-screen products; provision of information on environmental safety of sun-tan and sun-screen products; industrial analysis and research services.
01 - Chemical and biological materials for industrial, scientific and agricultural use
03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
Goods & Services
chemical and biochemical preparations for use in skin care products, moisturizers, skin care products for the prevention of sunburn, sun creams, sun-tan products and sun-screen products for the absorption of ultraviolet. skin care products for the prevention of sunburn; sun-tan and sun-screening preparations; sun creams; cosmetics and skin care products; preparations and substances for the conditioning, care and appearance of the skin, body and face; moisturizers.
01 - Chemical and biological materials for industrial, scientific and agricultural use
Goods & Services
Hydrocolloids, gelling agents, thickening agents, stabilizers, emulsifiers, binding agents, gums, modified starches, pectins and fibers for use in the manufacture of food and beverage products, pharmaceuticals, personal care products and cosmetics
89.
METHODS OF SUPPORTING GASTROINTESTINAL HOMEOSTASIS
Methods of feeding animals are disclosed whereby feed additives are provided that modulate the gut microbiome to prevent or treat dysfunctions in a gastrointestinal barrier. The present disclosure further relates to methods of feeding animals by providing feed additives that modulate the gut microbiome to prevent or treat infections.
01 - Chemical and biological materials for industrial, scientific and agricultural use
05 - Pharmaceutical, veterinary and sanitary products
31 - Agricultural products; live animals
Goods & Services
Mixtures of chemicals and microorganisms for increasing the nutritional value of animal fodder other than for veterinary use; acids for use in the preparation of animal foodstuffs; surfactants for the production of animal feed; antioxidants for use in manufacturing processes for feed and feed supplements; proteins for use in animal feed and feed supplement manufacturing processes; vitamins for the production of feed and feed supplements; antioxidants for the production of feed and feed supplements; enzymes to assist in digestion for use in the manufacture of animal feeds; enzymes for use in the manufacture of feed and feed supplements; chemical additives for use in the preparation of animal foodstuffs; chemical additives for use in the manufacture of animal foodstuffs. Dietary supplements for animals; feed additives for animals; medicated supplements for foodstuffs for animals; feed supplements for veterinary use; feeding stimulants for animals; medicated animal feed; medicated additives for animal foods; probiotic supplements for animals; enzymes for veterinary purposes; enzyme dietary supplements for animals; amino acids for veterinary purposes; protein supplements for animals; bacterial preparations for veterinary purposes; herbal detoxification agents for animals; mineral dietary supplements for animals; nutritional supplements for veterinary use. Animal foodstuffs; mixed animal feed; formula animal feed; animal feed preparations; yeast for animal fodder.
05 - Pharmaceutical, veterinary and sanitary products
29 - Meat, dairy products, prepared or preserved foods
30 - Basic staples, tea, coffee, baked goods and confectionery
Goods & Services
Dietary supplements and dietetic preparations; nutritional supplements; nutritional supplements for sports nutrition; nutritional supplement energy bars and gels; dietary food supplements in the nature of ready-to-eat protein bars; liquid nutritional supplements; protein shakes; nutritional recovery drinks; probiotic supplements; protein nutritional supplements; caffeine preparations for stimulative use. Fruit bars; nut bars; fruit and nut bars; milk based energy drinks. Energy bars; cereal bars; cereal-derived food bars; snack bars containing a mixture of grains, nuts and dried fruit; chocolate bars; high-protein cereal bars; pancakes.
The present invention relates to a meat analogue product comprising a texturized vegetable protein, a binder, a flavor and 0.5 to 10% (w/w) of a rapeseed protein isolate comprising napins and cruciferins, wherein the rapeseed protein isolate comprising napins and cruciferins is not texturized.
Synthetic biopolymers are disclosed, which can be engineered in terms of both their amino acid sequences and post-synthesis treatments to which they are subjected, to achieve desired gelation characteristics, particularly upon being exposed to physiological temperature (e.g., 37° C.). These synthetic biopolymers are therefore useful for injectable or implantable compositions for tissue repair, such as for bone void filler compositions. Examples of synthetic biopolymers are synthetic elastin-like polypeptides (ELPs) having polypeptide sequences with functional oligopeptide blocks that may include one or more hydrophobic blocks, one or more aggregation-enhancing blocks, and one or more β-sheet formation-inducing blocks. Optionally, one or more biomineralizing blocks may be present, to promote bone repair, growth, and/or strengthening.
A61L 27/46 - Composite materials, i.e. layered or containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
Methods of making a composite fabric for use in or as a medical implant component are disclosed whereby the method includes the steps of providing a textile comprising at least one strand having titer of 2-250 dtex and comprising fibers made from a biocompatible and biostable synthetic polymer; determining locations on the textile where a cut is to be made for an intended use of the textile; optionally pretreating the textile at least at the determined locations on at least one side of the textile with a high-energy source to activate the surface; solution coating the textile at least at a determined location with a coating composition comprising a biocompatible and biostable polyurethane elastomer and a solvent for the polyurethane; removing the solvent from the coated textile; and laser cutting the coated textile as obtained at least a one coated location with an ultra-short pulse laser; to result in a composite biotextile wherein polyurethane is present in an amount of 2.5-90 mass % based on composite biotextile and polyurethane is present at least at a laser-cut edge.
D06N 3/00 - Artificial leather, oilcloth, or like material obtained by covering fibrous webs with macromolecular material, e.g. resins, rubber or derivatives thereof
D06N 3/14 - Artificial leather, oilcloth, or like material obtained by covering fibrous webs with macromolecular material, e.g. resins, rubber or derivatives thereof with macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds with polyurethanes
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Phenazopyridine hydrochloride preparations in the nature of analgesics; Methenamine and Sodium Salicylate preparations in the nature of analgesics and antibacterial substances for medical purposes; medicinal preparations for the treatment of yeast infections; homeopathic medicine for use in the treatment of bacterial, yeast, and urinary tract infections
A computer-based method for determining a sunscreen composition comprising a plurality of UV filter substances, comprises the steps of selecting at least one constraint for at least one characteristic of the composition to be determined (step 30), the at least one constraint comprising a sunscreen performance target; selecting an optimization objective from a plurality of optimization objectives (step 50); and automatically determining the sunscreen composition as a composition of filter substances from a set of filter substances (step 100), the composition meeting the at least one constraint and being optimized with respect to the selected optimization objective. The automatic determination comprises the steps of generating a plurality of candidate compositions, determining a sunscreen performance of the candidate compositions using a performance simulation tool and comparing the determined sunscreen performance of the candidate compositions with the sunscreen performance target. The method allows for an automatic determination of an optimum sunscreen composition based on constraints and objectives, thus avoiding manual trial and error methods that are lengthy and do not always lead to the optimal result.
Disclosed embodiments concern a composition comprising mannan-derived oligosaccharides orycast cell wall product and vitamin C. vitamin E, vitamin D3, and selenium. The disclosedembodiments further concern a method of administering the above composition as a feedadditive to supplement the feed of. farm animals. particularly for sows and piglets. The disclosedmethod is for promoting the immunity of pigs.
C07C 29/42 - Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy groups, e.g. O-metal by reaction with aldehydes or ketones with compounds containing triple carbon-to-carbon bonds, e.g. with metal-alkynes
The present invention provides a method for reducing ammonia emission of animals comprising administering to the animals one or more proteolytic enzymes, i.e., proteases. The present invention also provides a feed composition suitable for the above methods and use thereof.
